Top Markets
Coin of the day
Ortivus AB (publ) Ortivus AB (publ)

Ortivus AB (publ)

ORTI-A
Rank in Stocks #35052
Ortivus AB (publ) focuses on developing and commercializing medical technology... Ortivus AB (publ) focuses on developing and commercializing medical technology solutions for the healthcare sector, serving clients both in Sweden and across the globe. Their offerings encompass the MobiMed Monitor, which tracks essential patient vital signs including ECG, blood pressure, and SpO2; MobiMed ePR, an electronic patient record system for documenting treatments and incidents; MobiMed Life, engineered for sophisticated monitoring and resuscitation; and MobiMed Cloud, enabling seamless multiplatform data sharing across Windows, web, iOS, and Android devices. Additionally, the company provides comprehensive support, implementation, training, and consulting services. Founded in 1985, Ortivus AB maintains its headquarters in Danderyd, Sweden.
Share Price
$0.22338707
Last synced: 2026-09-07
Market Cap
$4.51M
Change (1 day)
1.01%
Change (1 year)
106.71%
Country
SE
Trade Ortivus AB (publ) (ORTI-A)

Category

P/E ratio for Ortivus AB (publ) (ORTI-A)
P/E ratio as of 2026 TTM: 0
According to Ortivus AB (publ) latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Ortivus AB (publ) from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
42.58 -
US
29.69 -
FR
- -
JP
56.66 -
US
- -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.